Absence of mutations in NR2E1 and SNX3in five patients with MMEP (microcephaly, microphthalmia, ectrodactyly, and prognathism) and related phenotypes
© Kumar et al; licensee BioMed Central Ltd. 2007
Received: 13 February 2007
Accepted: 26 July 2007
Published: 26 July 2007
A disruption of sorting nexin 3 (SNX3) on 6q21 was previously reported in a patient with MMEP (microcephaly, microphthalmia, ectrodactyly, and prognathism) and t(6;13)(q21;q12) but no SNX3 mutations were identified in another sporadic case of MMEP, suggesting involvement of another gene. In this work, SNX3 was sequenced in three patients not previously studied for this gene. In addition, we test the hypothesis that mutations in the neighbouring gene NR2E1 may underlie MMEP and related phenotypes.
Mutation screening was performed in five patients: the t(6;13)(q21;q12) MMEP patient, three additional patients with possible MMEP or a related phenotype, and one patient with oligodactyly, ulnar aplasia, and a t(6;7)(q21;q31.2) translocation. We used sequencing to exclude SNX3 coding mutations in three patients not previously studied for this gene. To test the hypothesis that mutations in NR2E1 may contribute to MMEP or related phenotypes, we sequenced the entire coding region, complete 5' and 3' untranslated regions, consensus splice-sites, and evolutionarily conserved regions including core and proximal promoter in all five patients. Two-hundred and fifty control subjects were genotyped for any candidate mutation.
We did not detect any synonymous nor nonsynonymous coding mutations of NR2E1 or SNX3. In one patient with possible MMEP, we identified a candidate regulatory mutation that has been reported previously in a patient with microcephaly but was not found in 250 control subjects examined here.
Our results do not support involvement of coding mutations in NR2E1 or SNX3 in MMEP or related phenotypes; however, we cannot exclude the possibility that regulatory NR2E1 or SNX3 mutations or deletions at this locus may underlie abnormal human cortical development in some patients.
The MMEP phenotype and EEC syndrome represent syndromic forms of split-hand/foot malformation (SHFM), which occurs either as an isolated malformation or as a feature of many other conditions with overlapping clinical findings . SHFM can be caused by chromosome rearrangements or single gene mutations and is a genetically heterogeneous malformation with multiple gene loci having been identified .
Sorting nexin 3 (SNX3) is ubiquitously expressed and belongs to the sorting nexin family, which is involved in intracellular protein trafficking . Previously, SNX3 was found to be disrupted in its 3rd intron by a de novo balanced translocation t(6;13)(q21;q12) in a patient with MMEP (microcephaly, microphthalmia, ectrodactyly, and prognathism) and severe mental retardation . Thus, SNX3 was initially proposed as a reasonable candidate for MMEP in this patient, who did not harbor any SNX3 mutations on the normal chromosome . However, mutations involving SNX3 were not identified in a sporadic case with possible MMEP and normal karyotype [3, 4]. Thus, mutations in a gene close to SNX3 may contribute to MMEP and related phenotypes.
We propose that a gene(s) near the 6q21 translocation may underlie MMEP and related phenotypes in some patients. Here, we test the hypothesis that patients with MMEP or a related phenotype may harbor mutations in NR2E1 and/or SNX3. To test this hypothesis, we sequenced the entire NR2E1 coding region, consensus splice-site regions, complete 5' and 3' untranslated regions and evolutionarily conserved elements including core and proximal promoter in one patient with MMEP, three patients with possible MMEP or related phenotypes, and one patient with oligodactyly, ulnar aplasia, and a t(6;7)(q21;q31.2) translocation . We also sequenced the complete coding regions of SNX3 in three of five patients not previously examined for this gene.
Approval for this study was obtained from The University of British Columbia and Child & Family Research Institute. The research followed Canada's Tri-Council Statement on 'Ethical Conduct for Research Involving Humans'. Approval was also obtained through the Institutional Review Board of Self Regional Healthcare (Greenwood, SC). Consent from all patients was obtained for research purposes. Patients were ascertained and examined from five centers: The University of the Witwaterstrand, Johannesburg; The University of Cape Town, South Africa; Cedars-Sinai Medical Center, Los Angeles; Universita Cattolica, Rome; and The University of California, San Francisco. Patients were referred to the Greenwood Genetic Center for molecular research studies on split-hand/foot malformation. Controls were ascertained from the Greenwood Genetic Center.
All cases were sporadic and born to non-consanguineous parents. Patient 1 is the original patient with MMEP and t(6;13)(q21;q12) described previously by Viljoen and Smart . This is a 44-year-old Caucasian female with severe mental retardation, congenital microphthalmia causing complete blindness, central cleft lip and palate, ectrodactyly with absence of toes 2–4 on both feet, finger-like thumbs, and a broad, prominent jaw.
Patients 2–4 had normal blood chromosome analyses and were included in this study on the basis of having clinical features that significantly overlapped those of the MMEP phenotype. Patient 2 was felt to have possible MMEP versus an unusual variant of the ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome and has not been described previously. She is a Hispanic female with congenital microcephaly, bilateral microphthalmia, colobomas of the right iris and retina, left chorioretinal coloboma, left lacrimal duct stenosis, unilateral cleft lip and palate, dysplastic ears, soft tissue syndactyly of fingers 3–4 on the right hand, ectrodactyly of the left foot with a hallux and two digital rays, unilateral mixed versus sensorineural hearing loss requiring a hearing aid, sparse scalp hair and eyebrows, and narrow, deep-set nails. She had a prolonged hospitalization after birth and required gastrostomy tube placement. She had no evidence of a TP73L (previously, TP63, P63) mutation, which is known to be involved in split hand/foot malformation .
Patients 3 and 4 were felt to have an unusual variant of the EEC syndrome. A brief summary of their clinical findings was reported previously . Patient 3 is a 10-year-old Caucasian female with microcephaly, bilateral iris colobomas, microphthalmia with significant vision impairment, bilateral ectrodactyly of the hands and feet, unilateral cleft lip, and patchy alopecia of the scalp hair. She required gastrostomy feedings until age 9 due to ongoing problems with feeding, failure to thrive, and severe gastroesophageal reflux. A gastric emptying study revealed delayed emptying with a non-functioning section of the stomach and reverse peristalsis, which resolved with gastric Botox therapy. She has experienced significant dental problems due to ectodermal dysplasia. She attends a regular school program with visual assistance. Patient 4 is an African-American female seen at 3 months of age with congenital microcephaly, congenitally sealed eyelids with small to absent globes, ectrodactyly of the hands and feet, a notch in the upper lip resembling a mild midline cleft, absent scalp hair, underdeveloped eyelashes and eyebrows, underdeveloped nails, minor differences in ear shape, unilateral hearing loss, pelvic kidney, anteriorly placed anus, and tethered spinal cord. Both patients had no evidence of a TP73L mutation .
Patient 5 was included in the study on the basis of having a de novo chromosome translocation involving the 6q21 region (t(6;7)(q21;q31.2)) and congenital ulnar ray aplasia. His findings were described previously by Gurrieri et al. . He is a Caucasian male evaluated in the newborn period with congenitally bowed radii, absent ulnae, absence of fingers 3–5 on the right hand, syndactyly of fingers 2–3 and absence of fingers 4–5 on the left hand, and a cyst of the septum pellucidum. He did not have microcephaly, ocular abnormalities, or other features of the MMEP phenotype. We cannot exclude the possibility that breakage at 7q31 may disrupt a gene(s) involved in MMEP.
DNA amplification and sequencing
Sequencing was used to screen for SNX3 coding mutations in all 4 exons as previously described . We sequenced genomic NR2E1 using 20 PCR amplicons that covered the coding regions (1,146 bp), complete 5' and 3' UTRs (1,973 bp), exon-flanking regions including consensus splice-sites (1,719 bp), and evolutionarily conserved regions including the core and proximal promoter (1,528 bp). Polymerase chain reactions (PCR) and sequencing were performed as previously described . Sequences were visually inspected and scored blindly by at least two individuals using either Consed  or Sequencher (Gene Codes, Ann Arbor, MI). Every variant identified was confirmed by repeating the PCR and sequencing process. Confirmation of the g.21502T>C change in patient 2 and genotyping of unaffected parents and 250 controls without MMEP or related phenotypes was performed by restriction enzyme digestion of a 505-base pair PCR product using BsmBI. Primers and PCR conditions were as previously reported for 3' UTRb . The alteration created an additional BsmBI site, producing bands of 505, 278, and 227 base pairs in the heterozygous state.
Results and discussion
Absence of SNX3 coding mutations in MMEP or related phenotypes
To exclude the role of coding mutations in SNX3 in MMEP or related phenotypes, we sequenced all four coding exons in all patients not previously studied for this gene. No mutations were detected. The absence of coding mutations in SNX3 supports the role of other loci, such as NR2E1, in these disorders. We cannot, however, exclude the role of regulatory SNX3 mutations given that promoter and UTRs were not examined.
Absence of NR2E1 coding mutations in MMEP or related phenotypes
To determine whether patients with MMEP or related phenotypes harbor NR2E1 mutations, we sequenced the complete coding region, complete 5' and 3' UTR, consensus splice-sites, and evolutionarily conserved regions including the core and proximal promoter in all five patients. We generated approximately 33.5 kb of sequence data. We did not detect any synonymous nor nonsynonymous coding mutations.
One possibility is that the g.21502 T>C is an innocuous substitution that does not contribute to disease but rather represents a rare variant in the general population. An alternative interpretation is that heterozygous NR2E1 mutations may contribute to disease, which is supported by studies in mice heterozygous for Nr2e1 deletions that show premature cortical neurogenesis early in development , thereby suggesting dosage sensitivity for NR2E1. The presence of g.21502T>C in an unaffected parent may be due to incomplete penetrance of this variant. Alternatively, g.21502T>C may interact with another susceptibility variant arising de novo in the patient or inherited from the non-g.21502T>C-transmitting parent. Such a mechanism is supported by genetic studies in mice in which double heterozygous mutations at Nr2e1 and Pax6 are shown to enhance cortical phenotypes . It is important to note that the clinical phenotypes of the patients in this study may be attributable to different genetic mechanisms affecting similar developmental pathways.
MMEP and related phenotypes represent a spectrum of heterogeneous conditions for which multiple loci may be involved, including NR2E1 and SNX3 on Chromosome 6q21–22 [11, 12]. The present study does not support involvement of NR2E1 or SNX3 coding mutations in MMEP or related phenotypes. However, we cannot exclude the possibility that regulatory NR2E1 or SNX3 mutations, such as g.21502T>C of NR2E1, may underlie abnormal human cortical development in some families. In addition, we cannot exclude the possibility that deletions at NR2E1 or SNX3 may underlie MMEP, given that sequencing is unable to distinguish between homozygosity across loci versus large deletions. The lack of obvious mutations in NR2E1 and SNX3 contribute to the genetic complexity underlying this heterogeneous syndrome. Follow-up studies of other positional candidates such as LACE1, would be a next logical undertaking.
The authors acknowledge the patients and families who donated their time and blood samples. We thank Dr. Denis L. Viljoen (University of the Witwaterstrand, Johannesburg), Dr. Ronald Smart (University of Cape Town, South Africa), Dr. John M. Graham, Jr. (Cedars-Sinai Medical Center, Los Angeles), and Dr. Fiorella Gurrieri (Universita Cattolica, Rome) for providing us with patient samples. We also thank Tonya Moss for assistance in sequence analyses of SNX3. The authors are grateful to Brett S. Abrahams and Tracey D. Weir (Centre for Molecular Medicine and Therapeutics, Canada) for insight and helpful comments on the manuscript. This work was supported in part by grants from Jack and Doris Brown Foundation and British Columbia Institute for Children's & Women's Health (to RAK); Shriners Hospitals for Children, Grant #8510 (to DBE); South Carolina Department of Disabilities and Special Needs (SCDDSN) (to CES); and Canadian Institutes for Health Research (CIHR), CIHR Research and Development, and Canada Research Chair in Genetics and Behaviour (to EMS).
- Duijf PH, van Bokhoven H, Brunner HG: Pathogenesis of split-hand/split-foot malformation. Hum Mol Genet. 2003, 12 Spec No 1: R51-60. 10.1093/hmg/ddg090.View ArticlePubMedGoogle Scholar
- Xu Y, Hortsman H, Seet L, Wong SH, Hong W: SNX3 regulates endosomal function through its PX-domain-mediated interaction with PtdIns(3)P. Nature cell biology. 2001, 3 (7): 658-666. 10.1038/35083051.View ArticlePubMedGoogle Scholar
- Vervoort VS, Viljoen D, Smart R, Suthers G, DuPont BR, Abbott A, Schwartz CE: Sorting nexin 3 (SNX3) is disrupted in a patient with a translocation t(6;13)(q21;q12) and microcephaly, microphthalmia, ectrodactyly, prognathism (MMEP) phenotype. Journal of medical genetics. 2002, 39 (12): 893-899. 10.1136/jmg.39.12.893.View ArticlePubMedPubMed CentralGoogle Scholar
- Suthers G, Morris L: A second case of microcephaly, microphthalmia, ectrodactyly (split-foot) and prognathism (MMEP). Clinical dysmorphology. 1996, 5 (1): 77-79. 10.1097/00019605-199601000-00012.View ArticlePubMedGoogle Scholar
- Young KA, Berry ML, Mahaffey CL, Saionz JR, Hawes NL, Chang B, Zheng QY, Smith RS, Bronson RT, Nelson RJ, Simpson EM: Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependent. Behav Brain Res. 2002, 132 (2): 145-158. 10.1016/S0166-4328(01)00413-2.View ArticlePubMedPubMed CentralGoogle Scholar
- Roy K, Thiels E, Monaghan AP: Loss of the tailless gene affects forebrain development and emotional behavior. Physiol Behav. 2002, 77 (4-5): 595-600. 10.1016/S0031-9384(02)00902-2.View ArticlePubMedPubMed CentralGoogle Scholar
- Kumar RA, Chan KL, Wong AH, Little KQ, Rajcan-Separovic E, Abrahams BS, Simpson EM: Unexpected embryonic stem (ES) cell mutations represent a concern in gene targeting: lessons from "fierce" mice. Genesis. 2004, 38 (2): 51-57. 10.1002/gene.20001.View ArticlePubMedGoogle Scholar
- Jackson A, Panayiotidis P, Foroni L: The human homologue of the Drosophila tailless gene (TLX): Characterization and mapping to a region of common deletion in human lymphoid leukemia on chromosome 6q21. Genomics. 1998, 50 (1): 34-43. 10.1006/geno.1998.5270.View ArticlePubMedGoogle Scholar
- Monaghan AP, Grau E, Bock D, Schutz G: The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrain. Development. 1995, 121 (3): 839-853.PubMedGoogle Scholar
- Nishimura M, Naito S, Yokoi T: Tissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies. Drug Metab Pharmacokinet. 2004, 19 (2): 135-149. 10.2133/dmpk.19.135.View ArticlePubMedGoogle Scholar
- Gurrieri F, Cammarata M, Avarello RM, Genuardi M, Pomponi MG, Neri G, Giuffre L: Ulnar ray defect in an infant with a 6q21;7q31.2 translocation: further evidence for the existence of a limb defect gene in 6q21. Am J Med Genet. 1995, 55 (3): 315-318. 10.1002/ajmg.1320550314.View ArticlePubMedGoogle Scholar
- Viljoen DL, Smart R: Split-foot anomaly, microphthalmia, cleft-lip and cleft-palate, and mental retardation associated with a chromosome 6;13 translocation. Clinical dysmorphology. 1993, 2 (3): 274-277. 10.1097/00019605-199307000-00016.View ArticlePubMedGoogle Scholar
- de Mollerat XJ, Everman DB, Morgan CT, Clarkson KB, Rogers RC, Colby RS, Aylsworth AS, Graham JM, Stevenson RE, Schwartz CE: P63 mutations are not a major cause of non-syndromic split hand/foot malformation. Journal of medical genetics. 2003, 40 (1): 55-61. 10.1136/jmg.40.1.55.View ArticlePubMedPubMed CentralGoogle Scholar
- Kumar RA, Leach S, Bonaguro R, Chen J, Yokom DW, Abrahams BS, Seaver L, Schwartz CE, Dobyns W, Brooks-Wilson A, Simpson EM: Mutation and evolutionary analyses identify NR2E1-candidate-regulatory mutations in humans with severe cortical malformations. Genes Brain Behav. 2006,Google Scholar
- Gordon D, Abajian C, Green P: Consed: a graphical tool for sequence finishing. Genome Res. 1998, 8 (3): 195-202.View ArticlePubMedGoogle Scholar
- National Center for Biotechnology Information: dbSNP. [http://www.ncbi.nlm.nih.gov/projects/SNP]
- Roy K, Kuznicki K, Wu Q, Sun Z, Bock D, Schutz G, Vranich N, Monaghan AP: The Tlx Gene Regulates the Timing of Neurogenesis in the Cortex. J Neurosci. 2004, 24 (38): 8333-8345. 10.1523/JNEUROSCI.1148-04.2004.View ArticlePubMedPubMed CentralGoogle Scholar
- Stenman J, Yu RT, Evans RM, Campbell K: Tlx and Pax6 co-operate genetically to establish the pallio-subpallial boundary in the embryonic mouse telencephalon. Development. 2003, 130 (6): 1113-1122. 10.1242/dev.00328.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/8/48/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.